Versant Venture Management as of June 30, 2026
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics Common Stock (GLUE) | 47.3 | $77M | 3.2M | 24.20 | |
| Century Therapeutics Common Stock (IPSC) | 18.3 | $30M | 12M | 2.45 | |
| Jade Biosciences Common Stock (JBIO) | 13.6 | $22M | 992k | 22.22 | |
| Lenz Therapeutics Common Stock (LENZ) | 9.3 | $15M | 2.7M | 5.68 | |
| Contineum Therapeutics Common Stock (CTNM) | 5.5 | $8.9M | 543k | 16.39 | |
| CRISPR Therapeutics Common Shares (CRSP) | 5.0 | $8.1M | 149k | 54.54 | |
| Skye Bioscience Common Stock (SKYE) | 0.9 | $1.4M | 2.0M | 0.69 | |
| Tempest Therapeutics Common Stock | 0.2 | $299k | 270k | 1.11 |
